John Lu

5.1k total citations · 2 hit papers
27 papers, 3.3k citations indexed

About

John Lu is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John Lu has authored 27 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John Lu's work include Oral health in cancer treatment (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). John Lu is often cited by papers focused on Oral health in cancer treatment (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). John Lu collaborates with scholars based in United States, United Kingdom and Switzerland. John Lu's co-authors include David L. Lacey, David R. Meldrum, Yanping Song, Robert Rosenfeld, Alfred L. Goldberg, Qingsheng Jiao, H.Q. Han, Thomas C. Boone, Qing Chen and Xiaolan Zhou and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

John Lu

25 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

2020 740 citations Zunlong Ke, Joaquı́n Otón et al. Nature profile →
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

2010 731 citations Xiaolan Zhou, John Lu et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Lu United States	18	1.5k	695	589	497	395	27	3.3k
Xu Zhang China	36	2.7k 1.9×	598 0.9×	529 0.9×	505 1.0×	1.1k 2.9×	324	6.4k
W Wiktor-Jędrzejczak Poland	30	2.0k 1.4×	1.5k 2.2×	357 0.6×	218 0.4×	264 0.7×	222	5.5k
Fon‐Jou Hsieh Taiwan	37	1.3k 0.9×	604 0.9×	187 0.3×	209 0.4×	453 1.1×	142	3.8k
Gilberto Filaci Italy	34	843 0.6×	632 0.9×	669 1.1×	258 0.5×	220 0.6×	121	4.1k
Toshihiko Ishida Japan	35	1.3k 0.9×	582 0.8×	176 0.3×	527 1.1×	656 1.7×	220	3.9k
José Vassallo Brazil	32	1.1k 0.7×	1.2k 1.7×	126 0.2×	244 0.5×	499 1.3×	211	3.8k
Gaetano Bulfamante Italy	33	1.0k 0.7×	351 0.5×	192 0.3×	149 0.3×	341 0.9×	143	3.3k
David Gillis Australia	37	882 0.6×	255 0.4×	208 0.4×	511 1.0×	857 2.2×	144	4.2k
Mónica Marazuela Spain	38	1.1k 0.7×	933 1.3×	383 0.7×	322 0.6×	191 0.5×	202	5.2k
Gary Reynolds United Kingdom	45	1.3k 0.9×	1.2k 1.8×	304 0.5×	231 0.5×	231 0.6×	94	5.4k

Countries citing papers authored by John Lu

Since Specialization

Citations

This map shows the geographic impact of John Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lu more than expected).

Fields of papers citing papers by John Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lu. The network helps show where John Lu may publish in the future.

Co-authorship network of co-authors of John Lu

This figure shows the co-authorship network connecting the top 25 collaborators of John Lu. A scholar is included among the top collaborators of John Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lu. John Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Jason L., Jung-Ki Yoon, John Lu, et al.. (2025). Histological signatures map anti-fibrotic factors in mouse and human lungs. Nature. 641(8064). 993–1004. 9 indexed citations

Griffin, Michelle, Dario Boffelli, Nicholas Guardino, et al.. (2025). Growth arrest specific–6 and angiotoxin receptor–like signaling drive oral regenerative wound repair. Science Translational Medicine. 17(805). eadk2101–eadk2101.

Griffin, Michelle, Jason L. Guo, Jennifer Parker, et al.. (2025). Multi-omic analysis reveals retinoic acid molecular drivers for dermal fibrosis and regenerative repair in the skin. Cell stem cell. 32(9). 1421–1437.e6.

Liang, Norah E., Jennifer Parker, John Lu, et al.. (2024). Understanding the Foreign Body Response via Single-Cell Meta-Analysis. Biology. 13(7). 540–540. 2 indexed citations

Lu, John, et al.. (2023). Two structural switches in HIV-1 capsid regulate capsid curvature and host factor binding. Proceedings of the National Academy of Sciences. 120(16). e2220557120–e2220557120. 31 indexed citations

Ke, Zunlong, Joaquı́n Otón, Kun Qu, et al.. (2020). Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 588(7838). 498–502. 740 indexed citations breakdown →

Gao, Chen, Shuxun Ren, Junyi Yu, et al.. (2019). Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure. JACC Basic to Translational Science. 4(2). 161–172. 20 indexed citations

Calzone, Frank J., Elaina Cajulis, Petia Mitchell, et al.. (2013). Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab. PLoS ONE. 8(2). e55135–e55135. 28 indexed citations

Zhou, Xiaolan, John Lu, Yanping Song, et al.. (2010). Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival. Cell. 142(4). 531–543. 731 indexed citations breakdown →

10.

Colwell, Hilary H., Susan D. Mathias, Michelle Turner, et al.. (2010). Psychometric Evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): Reliability, Validity, Responsiveness, and Clinical Meaningfulness. The Oncologist. 15(3). 308–316. 21 indexed citations

11.

Shireman, Theresa I., et al.. (2010). Economic Analysis of Cinacalcet in Combination With Low-Dose Vitamin D Versus Flexible-Dose Vitamin D in Treating Secondary Hyperparathyroidism in Hemodialysis Patients. American Journal of Kidney Diseases. 56(6). 1108–1116. 16 indexed citations

12.

Beltran, Pedro J., Petia Mitchell, Elaina Cajulis, et al.. (2009). AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells. Molecular Cancer Therapeutics. 8(5). 1095–1105. 113 indexed citations

13.

Marcocci, Claudio, Philippe Chanson, Dolores Shoback, et al.. (2009). Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 94(8). 2766–2772. 106 indexed citations

14.

Beltran, Pedro J., Petia Mitchell, David Hwang, et al.. (2007). Inhibition of endocrine IGF-1 signaling in normal murine tissues and human tumor xenografts with AMG 479, a fully human anti IGF-1R monoclonal antibody. Molecular Cancer Therapeutics. 6. 4 indexed citations

15.

Vera‐Llonch, Montserrat, et al.. (2006). Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Supportive Care in Cancer. 15(5). 491–496. 126 indexed citations

16.

Lee, Howard, et al.. (2003). The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational study. BMC Nursing. 2(1). 2–2. 17 indexed citations

17.

Wang, Jinlin, et al.. (2002). Polyethylene Glycolated Recombinant TNF Receptor I Improves Insulitis and Reduces Incidence of Spontaneous and Cyclophosphamide-Accelerated Diabetes in Nonobese Diabetic Mice. Endocrinology. 143(9). 3490–3497. 10 indexed citations

18.

Lacey, David L., Hong Tan, John Lu, et al.. (2000). Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo. American Journal Of Pathology. 157(2). 435–448. 321 indexed citations

19.

Johnson, Daniel E., et al.. (1990). Diverse Forms of a Receptor for Acidic and Basic Fibroblast Growth Factors. Molecular and Cellular Biology. 10(9). 4728–4736. 94 indexed citations

20.

Meldrum, David R., R. Jeffrey Chang, John Lu, et al.. (1982). “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.. The Journal of Clinical Endocrinology & Metabolism. 54(5). 1081–1083. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact